Major shareholder Duan Lixin of Hunan Jiudian Pharmaceutical (stock code 300705.SZ) has completed a reduction of 1.13% of shares.

Announcement from Hunan Jiudian Pharmaceutical (300705.SZ): Shareholder Duan Lixin, who owns more than 5% of the company's shares, has cumulatively reduced his holdings by 5.595 million shares, accounting for 1.13% of the total share capital. Duan Lixin has decided to terminate the current reduction plan ahead of schedule, and the remaining shares that were not reduced will no longer be reduced during the remaining reduction plan period.